latest news in Biotech Investment

GRAIL Faces Investor Lawsuits Following Devastating Stock Crash

GRAIL Faces Investor Lawsuits Following Devastating Stock Crash

Menlo Park, Tuesday, 4 August 2026.
GRAIL faces an August 4, 2026 lead plaintiff deadline after allegations of misleading cancer trial data triggered a 50.55% stock collapse, erasing over $2.2 billion in market value.